Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes

J Biol Chem. 2017 Jun 16;292(24):10275-10287. doi: 10.1074/jbc.M116.770974. Epub 2017 Apr 24.

Abstract

Hepcidin is a liver-derived hormone that negatively regulates serum iron levels and is mainly regulated at the transcriptional level. Previous studies have clarified that in addition to hepatic iron levels, inflammation also efficiently increases hepatic hepcidin expression. The principle regions responsible for efficient hepcidin transcription are bone morphogenetic protein-responsive elements (BMP-REs) 1 and 2 as well as the signal transducer and activator of transcription 3-binding site (STAT-BS). Here, we show that the proinflammatory cytokine interleukin-1β (IL-1β) efficiently increases hepcidin expression in human HepG2 liver-derived cells and primary mouse hepatocytes. The primary region responsible for IL-1β-mediated hepcidin transcription was the putative CCAAT enhancer-binding protein (C/EBP)-binding site (C/EBP-BS) at the hepcidin promoter spanning nucleotides -329 to -320. IL-1β induces the expression of C/EBPδ but neither C/EBPα nor C/EBPβ in hepatocytes, and C/EBPδ bound to the C/EBP-BS in an IL-1β-dependent manner. Lipopolysaccharide (LPS) induced the expression of IL-1β in Kupffer cells and hepatocytes in the mouse liver; furthermore, the culture supernatants from the macrophage-like cell line RAW264.7 treated with LPS potentiated the stimulation of hepcidin expression in hepatocytes. The present study reveals that: 1) inflammation induces IL-1β production in Kupffer cells and hepatocytes; 2) IL-1β increases C/EBPδ expression in hepatocytes; and 3) induction of C/EBPδ activates hepcidin transcription via the C/EBP-BS that has been uncharacterized yet. In cooperation with the other pathways activated by inflammation, IL-1β pathway stimulation leads to excess production of hepcidin, which could be causative to anemia of inflammation.

Keywords: CCAAT enhancer-binding protein (C/EBP); gene transcription; hepatocyte; hepcidin; inflammation; interleukin 1 (IL-1).

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CCAAT-Enhancer-Binding Protein-delta / agonists*
  • CCAAT-Enhancer-Binding Protein-delta / antagonists & inhibitors
  • CCAAT-Enhancer-Binding Protein-delta / genetics
  • CCAAT-Enhancer-Binding Protein-delta / metabolism
  • Cells, Cultured
  • Culture Media, Conditioned
  • Hep G2 Cells
  • Hepatocytes / cytology
  • Hepatocytes / drug effects
  • Hepatocytes / immunology
  • Hepatocytes / metabolism*
  • Hepcidins / agonists*
  • Hepcidins / genetics
  • Hepcidins / metabolism
  • Humans
  • Interleukin-1beta / genetics
  • Interleukin-1beta / metabolism*
  • Kupffer Cells / cytology
  • Kupffer Cells / drug effects
  • Kupffer Cells / immunology
  • Kupffer Cells / metabolism
  • Lipopolysaccharides / toxicity
  • Macrophages / drug effects
  • Macrophages / immunology
  • Macrophages / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred ICR
  • Promoter Regions, Genetic* / drug effects
  • RAW 264.7 Cells
  • RNA Interference
  • Rats, Sprague-Dawley
  • Recombinant Proteins / metabolism
  • Up-Regulation* / drug effects

Substances

  • CEBPD protein, human
  • Culture Media, Conditioned
  • HAMP protein, human
  • Hepcidins
  • IL1B protein, human
  • Interleukin-1beta
  • Lipopolysaccharides
  • Recombinant Proteins
  • CCAAT-Enhancer-Binding Protein-delta